| content | ||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
Sulprostone
|
|
| Systematic (IUPAC) name | |
| (Z)-7-[(1R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-
(phenoxy)but-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide |
|
| Identifiers | |
| CAS number | |
| ATC code | G02 |
| PubChem | |
| Chemical data | |
| Formula | C23H31NO7S |
| Mol. mass | 465.56 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulprostone is an oxytocic.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||
